You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Russia

Feb 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Russia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Russia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Russia for free:

The Consumer Health in Russia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Russia?
  • What are the major brands in Russia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Market Development Underpins Consumer Health Value Growth

The Russian consumer health market experienced strong growth in the review period, supported by the entry of new products and new players to the market. General economic growth enabled consumers to spend more on consumer health, supporting growth of retail chains. The development of chained retailers closed the virtual cycle of the consumer health market, widening the assortment of products available to increasingly sophisticated customers, who have also become more aware of health trends. Media coverage of healthcare issues strengthened during the review period supported by the health and wellness trend, resulting in many consumers taking vitamins and dietary supplements on a regular basis. Growth of fitness centre chains boosted sales of sports nutrition products.

Government Regulation Results in Market Turbulence

Towards the end of the review period the government’s focus on the pharmaceutical industry increased resulting in regulations setting obligatory manufacturer price registration from April 2010. Regalement limiting mark-ups made by wholesalers and retailers was issued leading to changes in the procurement policies of retailers. This had a varying impact on the positions of market players, benefiting some while damaging others.

Domestic Companies Exploit Opportunities

Currency fluctuation caused by economic instability created a beneficial position for companies with local manufacturing facilities in Russia. Dramatic changes in rouble exchange rates against the dollar and euro boosted prices towards the end of the review period. Along with decreased consumer purchasing power this caused consumer preferences to drift towards products made by local manufacturers. After the situation stabilised, local manufacturers who had made an effort to benefit from the situation found that their market value shares had increased.

Growth Targets Among Pharmacies Results in Quality Changes

During the review period the distribution share of chained pharmacies approached 50% with chained players dominating in the largest towns. After a sweeping consolidation process came to an end, many players became concerned with operational efficiencies and attractiveness of their outlets. Increased competition forced retailers to apply efficiencies, improve service levels and widen the assortment and services of their ranges.

Expansion to Regions and Economic Recovery Set to Drive Overall Growth

The post-crisis economic recovery trend noted towards the end of the review period is expected to continue in the following five years, driving demand growth for consumer health products. The attraction and mimicking of European living standards and increasing disposable income will continue. By the end of the forecast period, this will positively affect the largest and middle-sized cities and will set a beachhead for expansion into smaller towns and rural areas. Penetration of chained retailers into regions will bring a wider assortment of consumer health products to new customers in new areas.

Table of Contents

Table of Contents

Consumer Health in Russia - Industry Overview

EXECUTIVE SUMMARY

Market Development Underpins Consumer Health Value Growth

Government Regulation Results in Market Turbulence

Domestic Companies Exploit Opportunities

Growth Targets Among Pharmacies Results in Quality Changes

Expansion to Regions and Economic Recovery Set to Drive Overall Growth

KEY TRENDS AND DEVELOPMENTS

Government Stimulates Localisation of International Companies

Legislation Changes Lead to Market Turbulence

Poor Nutrition Boosts VDS and Weight Management Products

Dietary Supplements Becomes Better Regulated

Preventative Medication Affects Sales Growth

CITY KEY TRENDS AND DEVELOPMENTS

Moscow

St Petersburg

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Sales of Consumer Health by City: Value 2005-2010
  • Table 6 Sales of Consumer Health by City: % Value Growth 2005-2010
  • Table 7 Consumer Health Company Shares by Value 2006-2010
  • Table 8 Consumer Health Brand Shares by Value 2007-2010
  • Table 9 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 10 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 11 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 12 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015
  • Table 13 Forecast Sales of Consumer Health by City: Value 2010-2015
  • Table 14 Forecast Sales of Consumer Health by City: % Value Growth 2010-2015

APPENDIX

Consumer Health Market Regulation

De-reimbursement

Bio-equivalents/generics

Advertising

Packaging and Labelling

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Russia - Company Profiles

Akrikhin OAO - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Akrikhin OAO: Competitive Position 2010

Berlin Chemie Russia - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Berlin Chemie Russia: Competitive Position 2010

Evalar ZAO - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Evalar ZAO: Competitive Position 2010

Ferrosan Consumer Health OOO - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Ferrosan Consumer Health OOO: Competitive Position 2010

Novartis Consumer Health OOO - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Novartis Consumer Health OOO: Competitive Position 2010

Nycomed Russia-CIS - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Nycomed Russia-CIS: Competitive Position 2010

Pharmstandart OAO - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Pharmstandart OAO: Competitive Position 2010

Sandoz ZAO - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 19 Sandoz ZAO: Competitive Position 2010

Sanofi-Aventis Russia - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 21 Sanofi-Aventis Russia: Competitive Position 2010

Unipharm Russia - Consumer Health - Russia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 23 Unipharm Russia: Competitive Position 2010

Adult Mouth Care in Russia - Category Analysis

HEADLINES

TRENDS

  • Strong marketing support diminished in 2010. A high sales base led to a decrease in value growth rates. Growth of the previous years was driven by strong marketing for the leading brands therefore after the marketing efforts weakened, growth rates decreased. Widening distribution in regions and growing consumer awareness of the products maintained growth at a relatively high level.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2009 demand for Metrogil denta by Unique Pharmaceutical Laboratories spiked. This was caused by its lower price than its closest competitors and many consumers who had just become more price-sensitive due to the economic downturn, decided to try it. In 2010 the company registered the steepest decline in value sales, from a 44% share in 2009 to 33% in the following year. However, the company still retained its lead in the sector.

PROSPECTS

  • Rising income levels resulted in many people seeking treatment for mouth problems at private health clinics. However, in times of economic downturn those people able to pay for professional expensive treatments reduced significantly. Tightening control of UTC sales will prevent people from purchasing Rx medicines UTC, what will drive steady growth of OTC adult mouth care.

CATEGORY DATA

  • Table 15 Sales of Adult Mouth Care: Value 2005-2010
  • Table 16 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 17 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 18 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 19 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 20 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Russia - Category Analysis

HEADLINES

TRENDS

  • The analgesics sector is determined by consumer preferences and companies that are able to effectively manage it through advertising and work with pharmacies to increase their sales way above market growth. Although combination products with acetaminophen remain very popular, products with ibuprofen recorded the highest growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • More attentive and selective procurement by pharmacies was a result of government regulations. Manufacturing companies with strong market positions which dared to launch massive advertising campaigns during the economic downturn were able to benefit from the situation. Aggressive advertising led to sales growth of some brands while some of the longest standing saw growth decline.

PROSPECTS

  • Government intervention in the pharmaceutical sector, implementation of Pharma 2020 and Health 2020 programmes are expected to influence the whole market and the analgesics category over the forecast period. Implementation of government programmes creates a priority for manufacturers with local production facilities. All local manufacturers are expected to meet GMP standards by 2014. The need for financial investment activities will push prices up, which will fly in the face of government price regulation. Regulation and change in consumer behaviour over economy brands will lead to a withdrawal of economy brands leaving a niche for private label. Customers who regularly buy analgesics will rely on familiar brands, advice from pharmacists as well as the internet community.

CATEGORY DATA

  • Table 21 Sales of Analgesics by Category: Value 2005-2010
  • Table 22 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 23 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 24 Analgesics Company Shares by Value 2006-2010
  • Table 25 Analgesics Brand Shares by Value 2007-2010
  • Table 26 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 27 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Russia - Category Analysis

HEADLINES

TRENDS

  • The declining trend in 2009 continued into 2010 with price deflation and volume sales stagnation. Price regulations in place since April 2010 brought more depression to the market. Nevertheless, the second quarter of the year marked growth in disposable incomes which led to a switch in consumer preferences from economy to standard brands. Since the third-quarter prices on sector products registered slight growth. This recovery trend lasted until the end of the year leading to a strong performance in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ivax Pharmaceuticals was a strong leader in calming and sleeping products in 2010 with a 16% value share, although its share dropped by one percentage point over the previous year. The company’s Novo-Passit brand has a strong base of loyal customers. Although its share decreased, its actual value sales increased by 2%. In addition, it is sold in a wide range of pack sizes, from 10-30 units. Consequently, many consumers seeking to economise were able to continue to afford the brand by simply opting for smaller pack sizes.

PROSPECTS

  • Economic recovery in Russia and its development into regions will lead to busier lifestyles and an increase in stress levels among consumers. The expansion of retail chains will lead to growing availability of a wide assortment of calming and sleeping products. The growing availability of new generation calming products which are more convenient to use will widen their consumer base. These factors will drive growth of the sector in the forecast period.

CATEGORY DATA

  • Table 28 Sales of Calming and Sleeping: Value 2005-2010
  • Table 29 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 30 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 31 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 32 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 33 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Russia - Category Analysis

HEADLINES

TRENDS

  • The main event in 2010 was the introduction of new government initiatives around price control. Many leading brands were put on the List of Vital and Essential Drugs. This in some cases caused additional obstacles for some players and created new opportunities for others who better managed to keep pace with the new regulations. For example, Novartis did not register prices for its nasal sprays Otrivin and Dlyanos (these drugs contain Xylometazolin, so prices must be registered), which led to the disappearance of the latter from the market for a few months in the middle of 2010, heavily impacting its sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Consumer Health and Pharmstandart were the steady leaders in cough, cold and allergy (hay fever) remedies in 2010 and accounted for 12% and 10% value shares respectively. Although Novartis suffered from the turbulence caused by government regulations, losing market share in nasal sprays and nasal drops, it still remained the leading player in the sector. The company’s developed distribution network and strong reputation of its brands, recognised for their quality, enabled it to remain a leading player. Meanwhile Pharmstandart’s best-selling brands were Terpinkod and Kodelak, both of which had a questionable reputation because these codeine-containing medicines are known to cause addiction.

PROSPECTS

  • Having many fast acting effective drugs available, Russian consumers became more conscious of the issue of safe treatments. In allergy remedies new generation drugs with lower sedative effects will gain market share in the forecast period. Cough and cold remedies will see strong indirect competition from antiviral preparations and nutritional supplements. Consumers will become to understand that preventative treatments are a good way of avoiding long periods of sick leave.

CATEGORY DATA

  • Table 34 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 35 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 36 Sales of Decongestants by Category: Value 2005-2010
  • Table 37 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 38 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 39 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 40 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 41 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 42 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 43 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Russia - Category Analysis

HEADLINES

TRENDS

  • The summer 2010 was characterised by a rise in the number of Russians choosing to travel. After the beginning of economic recovery many people who had spent the summer of 2009 at home went on holiday. Digestive remedies traditionally feature in travellers’ bags and therefore registered sales growth. The extreme temperatures during the summer months triggered a travel boom in Moscow and other cities of the European part of Russia. The number of people suffering from digestive problems related to spoiled food also increased, stimulating demand for digestive remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010 Sanofi-Aventis was the leading player in digestive remedies, accounting for a 15% value share. The company benefited from a strong portfolio of brands, including No-spa and Festal, which are well-recognised by Russians. The launch of No-spa in new packaging combined with a massive advertising campaign supported the brand’s sales. Berlin Chemie ranked second with a 10% share of value sales. Its strong Mezym brand helped the company to achieve a 40% value share of digestive enzymes.

PROSPECTS

  • Sales of digestive remedies will be affected by the popularity of probiotic products. Food manufacturers also use digestive stimulation as a main point in positioning widely advertised products, such as pro-biotic yoghurts. Promotion will stimulate consumer consumption of these products on a regular basis lowering demand for digestive remedies. Growth of digestive remedies will be provided by sales of newly launched safe and effective products. Such launches and promotions will require solid research and development as well as large marketing budgets, all of which makes the sector attractive to large multinationals, who had dominated the sector in 2010.

CATEGORY DATA

  • Table 44 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 45 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 46 Digestive Remedies Company Shares by Value 2006-2010
  • Table 47 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 48 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 49 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Russia - Category Analysis

HEADLINES

TRENDS

  • Many consumers of ear care are children. The implementation of national programmes aimed to support parents giving birth to second children resulted in continued growth in the birth rate in 2010. Ear problems often start when suffering colds or flu when the immune system is weak. In 2010 the cold and flu period was unusually short in central Russia which did not support growth in ear care sales. The growth that was achieved could have been higher if the changeable spring weather transition period had lasted longer.

SWITCHES

COMPETITIVE LANDSCAPE

  • Otipax by Biocodex led sales in 2010 with a value share of 27%. Otipax and Otinum dominated the market being close substitutes. Paediatricians and ENT doctors usually do not differentiate between these two brands and leave patients to make the purchasing decision to themselves. Otipax is known to be a milder medicine and many parents prefer it when a problem is not very serious, which may give the brand a slight advantage.

PROSPECTS

  • Ear care is expected to see steady but unspectacular growth during the forecast period, with a constant value CAGR of 4%. Growth will be supported by economic recovery and rising consumer income levels. Growing awareness of modern treatments available and recommendations by professionals will support the growth.

CATEGORY DATA

  • Table 50 Sales of Ear Care: Value 2005-2010
  • Table 51 Sales of Ear Care: % Value Growth 2005-2010
  • Table 52 Ear Care Company Shares by Value 2006-2010
  • Table 53 Ear Care Brand Shares by Value 2007-2010
  • Table 54 Forecast Sales of Ear Care: Value 2010-2015
  • Table 55 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Russia - Category Analysis

TRENDS

  • There are no available OTC emergency contraception in Russia. All medicines are Rx only.

Eye Care in Russia - Category Analysis

HEADLINES

TRENDS

  • The economic situation stabilised in 2010 and the first shoots of economic growth appeared. The improved economic situation supported a hidden decline in unemployment. Longer office working hours resulted in recovery in eye care demand which in turn led to price adjustments.

SWITCHES

COMPETITIVE LANDSCAPE

  • Santen ranked first with a value share of just over 12% of eye care sales. Johnson & Johnson followed closely, also on 12%. Santen is present with the strong brand Oftan, widely recommended by ophthalmologists while Visine by Johnson & Johnson was also a best seller. The latter benefited from strong brand recognition, in-store promotion and growth in its base of loyal customers.

PROSPECTS

  • Eye care is expected to register a moderate performance during the forecast period, with overall constant value growth of 23%. Growing concern about health and the time spent working in front of computers will lead to higher demand for eye care. Elderly people also concerned with their eye health will create demand for eye care products. In general, consumers paying more attention to preventative treatment will put eye care medicines in their must-have list of consumer health in order to prevent glaucoma, cataract and other eye diseases.

CATEGORY DATA

  • Table 56 Sales of Eye Care by Category: Value 2005-2010
  • Table 57 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 58 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 59 Eye Care Company Shares by Value 2006-2010
  • Table 60 Eye Care Brand Shares by Value 2007-2010
  • Table 61 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 62 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Russia - Category Analysis

HEADLINES

TRENDS

  • After new strict price regulations were introduced in April 2010, pharmacy chains became less interested in selling low-priced products. Many herbal/traditional remedies were economy products and their sales were affected. In September the regulations changed once again, becoming more flexible and enabling pharmacists to charge more on popular brands not on the Vital and Essential Drugs list. After the regulation was loosened pharmacists became more motivated and put herbal/traditional products beloved by customers back on shelves.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products remained highly fragmented, with no single company having a value share of more than 6% in 2010 and the top five players accounting for 19%. In 2010 Warner-Lambert Russia led sales with its Halls medicated confectionery brand benefiting from wide distribution and large loyal customer base. Used for prophylaxis during coughing bouts and available in almost every small shop, Halls remained popular in Russia.

PROSPECTS

  • The forecast period is expected to see mixed dynamics in sales of herbal/traditional products. In the categories where more efficient and at the same time safe non-herbal remedies are available, sales could suffer from consumer trading-up to standard consumer health. In those categories where herbal remedies are traditionally dominant, an economic rebound will lead to sales growth. Growing consumer concern about components in remedies they buy will lead to new product launches, which will drive sector growth in the forecast period.

CATEGORY DATA

  • Table 63 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 64 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 65 Herbal/Traditional Products Company Shares 2006-2010
  • Table 66 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 67 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 68 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Russia - Category Analysis

HEADLINES

TRENDS

  • None of the top ten brands within medicated skin care were put on the Vital and Essential drugs list. This enabled retailers to exploit the market demand and supply and to increase sales. Russian consumers place considerable emphasis on appearance and a well-groomed appearance is symbolic of social status and career success. Category growth was stimulated by significant growth in consumer awareness about products available in the market. A warm summer and travel boom led to demand growth in topical antifungals, sales of which rose 6% in current value terms in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Consumer Health OOO led sales in medicated skin care with 7% of the market value with strong positions of Lamisil, Fenistil, Elidel and Procto-Glyvenol brands. The leading brand was Relief of Sagmel with 6% of market value.

PROSPECTS

  • Consumer attitudes will continue to evolve during the forecast period and medicated skin care is expected to see strong growth. A spread in internet coverage, with more people involved in discussions about skin disorders and the ongoing spread of modern chained chemists/pharmacies across the country, and more literature available on common disorders will drive the growth. Consumers will become more aware of the treatments on offer. Economic recovery after the crisis years will support this trend. The highest growth will be seen in vaginal antifungals and topical allergy remedies/antihistamines, each of which is expected to achieve a CAGR of 8% in constant value terms.

CATEGORY DATA

  • Table 69 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 70 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 71 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 72 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 73 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 74 Acne Treatments Brand Shares by Value 2007-2010
  • Table 75 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 76 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Russia - Category Analysis

HEADLINES

TRENDS

  • Russian authorities have become increasingly concerned with the problem of smoking. In 2010 regulations on the subject were reviewed twice. New initiatives proposed a ban on tobacco smoking in public places, a tightening of packaging requirements for tobacco manufacturers, and requirements for retailers to sell tobacco products only in shops with areas exceeding 50 sq m. A gradual annual increase of tobacco taxes was proposed to reach European levels by 2015. A tightening of regulations made smoking less attractive and complicated causing smokers to think about quitting the habit.

SWITCHES

COMPETITIVE LANDSCAPE

  • The Nicorette brand by Johnson & Johnson remained the absolute leader in all three NRT categories sold on the Russian market in 2010 accounting for 97% of retail value sales.

PROSPECTS

  • A tightening of regulations related to tobacco smoking will be the main driver of the sector in the forecast period especially as there will be a ban on smoking in public places in the Moscow region in 2011 and in all other regions of Russia by 2014. There will also be a ban on cigarette sales in kiosks and shops with an area of less than 50 sq m. A gradual increase in a cigarette tax of 30-40% annually and requirements for manufacturers to print illustrations of diseases caused by smoking on cigarette packs are included in the new legislation as well as a ban on advertising for tobacco products. This legislation is likely to prove highly beneficial for sales of NRT smoking cessation aids.

CATEGORY INDICATORS

  • Table 77 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 78 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 79 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 80 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 81 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 82 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 83 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 84 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

OTC Triptans in Russia - Category Analysis

TRENDS

  • There are no available OTC Triptans in Russia. All medicines are Rx only.

Sports Nutrition in Russia - Category Analysis

HEADLINES

TRENDS

  • In the first half of 2010 many loyal customers reduced their consumption of sports nutrition products due to the economic downturn and uncertainty over the economy. Extremely warm weather during the summer 2010 also disturbed everyday activities of many fitness club members, with many people trying to escape from cities to the countryside and skipping their training. This led to lowered consumption of sports nutrition.

COMPETITIVE LANDSCAPE

  • Haleko led sales in 2010 with a 20% share of value sales. Its Multipower Advances Protein brand has been available on the Russian market for many years and has gained loyal customers and the respect of professionals. Its high quality and standard price made it a top-selling brand.

PROSPECTS

  • The development of fitness centres chains, growth of distribution and widening assortment will continue driving growth of the sector until the end of the forecast period. Increasing gym membership and sports activity will result in a wider range of consumers becoming familiar with sports nutrition. Economic recovery will lead to an increase in purchasing power which will be reflected in growth in sports nutrition consumption.

CATEGORY DATA

  • Summary 24 Sports Nutrition, Category Rankings 2010
  • Table 85 Sales of Sports Nutrition: Value 2005-2010
  • Table 86 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 87 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 88 Sports Nutrition Company Shares 2006-2010
  • Table 89 Sports Nutrition Brand Shares 2007-2010
  • Table 90 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 91 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Russia - Category Analysis

HEADLINES

TRENDS

  • During the first half of 2010 sales of vitamins and dietary supplements declined in value terms. The seasonal decline was deepened by economic uncertainty, making people reduce their costs and switch from expensive brands to cheaper ones or avoid any unnecessary purchases. Demand started recovering at the end of the second quarter when the perspective of the Russian economy became more optimistic and consumers more confident. Over the longer term, demand for vitamins and dietary supplements has grown since the beginning of the review period supported by popular talk-shows on TV dedicated to health issues and ongoing manufacturers’ marketing efforts.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Pharmstandart remained the leading player in vitamins and dietary supplements, increasing its value share by one percentage point. Strong distribution competences along with a large marketing budget created an advantageous position for this player. Its Komplivit brand benefited from the economic difficulties being more economical than the more expensive vitamins of other large companies.

PROSPECTS

  • At the end of the review period Russia had entered a growth stage in the economic circle and a growing economy will be strongly associated with busier lifestyles and stress. Growing income levels will allow people to spend more on their health and beauty. Increasing access to the internet bringing awareness of health threats and means of prevention will widen the consumer base. This trend is expected to support good growth in vitamins and dietary supplements during the forecast period. Active marketing campaigns of the largest manufacturers will drive growth of the category in the forecast period. Domestic players such as Evalar and Akvion will be keen to further expand their ranges, focusing on offering innovative and high-quality products at affordable prices. Both will gain market share in dietary supplements during the forecast period. Pharmstandart will also strengthen its position launching new products. Large multinationals will benefit from market consolidation and partnering with local manufacturers to localise production, making their products affordable to a wider range of consumers on a regular basis.

CATEGORY DATA

  • Summary 25 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 92 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 93 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 94 Dietary Supplements by Positioning 2005-2010
  • Table 95 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 96 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 97 Vitamins Brand Shares by Value 2007-2010
  • Table 98 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 99 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 100 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Russia - Category Analysis

HEADLINES

TRENDS

  • Lack of dynamics and imbalanced diets are leading to obesity among many urban dwellers in Russia with almost 20% of city populations estimated to be obese. The mainstream stereotype that for a woman to be beautiful she should be slender, led to stable demand for weight loss products and practices. A wide variety of diets and home-made recipes to aid weight loss used to be very popular among Russian women until packed ready-to-use solutions were introduced to the market. At the end of the review period a wide assortment of convenient weight-loss products appeared. The supply was supported by growing economic growth and increasing purchasing power of the intended audience. Increases in income have led to development of the sector with more products offered to the market. Effects of the economic downturn of 2008-2009 continued into 2010 resulting in a decline in sector sales. However, by the end of 2010 a recovery trend was notable.

COMPETITIVE LANDSCAPE

  • Herbalife International led sales in 2010 with a 20% value share. The company had the longest presence in the Russian market. Its products are widely known and used even though some negative perceptions of the company still remain. Herbalife International benefited from high quality products whose efficiency was high and which benefited from direct sales marketing. The years of recent economic crisis helped to sustain the company’s customer base.

PROSPECTS

  • The number of overweight people in Russia will continue to grow towards the end of the forecast period. In Russia an extremely low percentage of people are active in sports which in combination imbalanced diets, causes them to become overweight. Promotion of healthier lifestyles through mass media and growing incomes will provide demand growth. New regulations requiring the obligatory registration of dietary supplements will lead to an increase in market transparency. The image of weight loss supplements will improve and the customer base widened. Domestic players are expected to gain shares against those of internationals, benefiting from high quality products, lower prices and a wide distribution network.

CATEGORY DATA

  • Table 101 Sales of Weight Management: Value 2005-2010
  • Table 102 Sales of Weight Management: % Value Growth 2005-2010
  • Table 103 Weight Management Company Shares 2006-2010
  • Table 104 Weight Management Brand Shares 2007-2010
  • Table 105 Forecast Sales of Weight Management: Value 2010-2015
  • Table 106 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Russia - Category Analysis

HEADLINES

TRENDS

  • Wound care remains a mature sector featuring products such as bandages, plasters and cotton-wool being produced for many years. Manufacturers suffered from intense competition and commoditisation of their product leading to declining margins. New players came onto the market in the review period with their more sophisticated looking products aiming to solve particular problems, widen the customer base and marked a new stage of category development. By 2010 many traditional local manufacturers had completed production reorganisation and product assortment differentiation and began bringing new products, new packaging and new brands to the market.

COMPETITIVE LANDSCAPE

  • Veropharm was a strong leader in wound treatments in 2010, accounting for a 28% value share, despite seeing its share decline by one percentage point over the previous year. The company benefited from its especially wide assortment. Its production includes over 130 variants of plasters. The company also had the widest distribution within wound treatments, thanks to its relationship with the largest pharmacy chain 36.6. In 2010 the company lost value share gained during 2009 which had been achieved through attractive pricing of its products and wide assortment including low priced single-unit packs.

PROSPECTS

  • Constant value sales of wound treatments are expected to stagnate over the forecast period. This is a largely a mature product area with traditional wound treatment sales expected to decline due to price competition and household stock growth by the end of the review period. However, regulations related to first aid kits will push sales at the beginning of the forecast period. The second and longer lasting driver of sector stability will be growing awareness of customers about new products available and switches of consumption towards more convenient but more expensive solutions.

CATEGORY DATA

  • Table 107 Sales of Wound Care by Category: Value 2005-2010
  • Table 108 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 109 Wound Care Company Shares by Value 2006-2010
  • Table 110 Wound Care Brand Shares by Value 2007-2010
  • Table 111 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 112 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Hawthorn
            • Isoflavones
            • Rosehip
            • Sabelnik
            • Topinambur
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Yeast
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market Sizes
  • Company Shares
  • Brand Shares
  • Distribution
  • Analysis by Format
  • Analysis by Positioning
  • Analysis by Type
  • Herbal/Traditional vs Standard
  • Pricing

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Country Report

Future Demographic